Using JAK Inhibitors for Myelofibrosis
"We are thankfully starting to be blessed with more options than we've ever had," but "in the frontline proliferative setting, ruxolitinib has remained the standard of care."
Source: medscape.com
Properly Using News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Properly Using. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Properly Using Today - Breaking & Trending Today